Urteste develops diagnostic tests for more than ten of the most common cancers (breast, pancreatic, prostate, kidney, colorectal, liver, bile duct, stomach, lung, throat, ovary, uterus, blood and nervous system cancer). The company’s most advanced projects involve tests for pancreatic (the PANURI project) and prostate cancer (the EASY-TEST project).Medical experiments have been completed as part of the PANURI and EASY-TEST projects, which have shown high sensitivity and specificity parameters. Diagnostic test prototypes have been developed and patent applications have been submitted as part of projects cancers concerning liver, lung, colon, kidney, corpus uteri. In other projects, works are carried out for the purposes of detecting test prototypes and qualifying compounds for clinical trials.

Progress in Urteste projects